QA: Procyon CORP in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000812306_2020_Procyon_CORP.pdf

Logs

Graph

Absolute values for 0000812306, Procyon CORP

  xvar xval
0 AssetsCurrent 1,593,795
1 IntangibleAssetsNetIncludingGoodwill 17,000
2 PropertyPlantAndEquipmentNet 488,460
3 remainder_Assets 335,677
4 LiabilitiesCurrent 375,935
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 1,426,741
8 SellingGeneralAndAdministrativeExpense 1,430,365
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 1,682,056
11 remainder_Revenues 4,223,630
12 remainder_NetIncome 556
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 2,434,932
1 Liabilities 375,935
2 Expenses 4,539,162
3 Revenues 4,223,630
4 StockholdersEquity 2,058,997
5 NetIncome -314,976
6 ComprehensiveNetIncome -314,976
7 BaseVar 5,787,108
8 EconomicCapitalRatiobeforeLimitedLiability 2.97
9 EconomicCapitalRatio 3.67

Edgar->Model Mapping

Feature Distribution

Change over Time